INTELGENX TECHNOLOGIES CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.164 USD | -1.61% |
|
-0.61% | +18.75% |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the IntelGenx Fourth Qua...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Companyâs film technologies, including VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, allows for pharmaceutical products that address unmet medical needs. It provides comprehensive pharmaceuticals services to pharmaceutical partners, including research and development (R&D), analytical method development, clinical monitoring, IP and regulatory services. Its manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production. Its product portfolio includes Migraine (Rizatriptan), Erectile Dysfunction (Tadalafil), Schizophrenia (Lozapine), Neurodegenerative, Opioid Dependence (Buprenorphine / Naloxone) and others.
Sector
Pharmaceuticals
Calendar
2024-05-07
- Annual General Meeting
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.164
Average target price
-
| 1st Jan change | Capi. | |
|---|---|---|
| +18.75% | 28.64M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- IGXT Stock
- News IntelGenx Technologies Corp.
- Transcript : IntelGenx Technologies Corp., Q4 2023 Earnings Call, Mar 21, 2024
